U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828458) titled 'Determining Elements of Anti-Fungal Immunity in BURN Patients' on Feb. 10.
Brief Summary: Scientific justification Invasive fungal diseases (IFDs) pose a substantial threat, especially in immunocompromised patients, necessitating urgent research focus and therapeutic advancements. The IFI-BURN study, involving a cohort of patients with severe burn injury (n=276), revealed a significant IFD incidence of 31.6% and underscored their critical impact on morbidity and mortality. While fungi are present everywhere, for moulds within the environment and for yeasts within our microbiota, why certain patients develop IFDs and others do not, r...